Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andrew W. Hahn
Potential Roles for PD‐1 and Cabozantinib in Patients With Metastatic Non‐Clear Cell Renal Cell Carcinoma
Oncologist
Cancer Research
Medicine
Oncology
Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New Onset Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Prognostic Value of Granulocyte Colony-Stimulating Factor in Patients With Non-Metastatic Clear Cell Renal Cell Carcinoma
Oncotarget
Oncology
Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Beta-1,4-Galactosyltransferase II Predicts Poor Prognosis of Patients With Non-Metastatic Clear-Cell Renal Cell Carcinoma
Tumor Biology
Medicine
Cancer Research
Systemic Therapy for Metastatic Non–Clear-Cell Renal Cell Carcinoma: Recent Progress and Future Directions
Hematology/Oncology Clinics of North America
Oncology
Hematology
High CXC Chemokine Receptor 1 Level Represents an Independent Negative Prognosticator in Non-Metastatic Clear-Cell Renal Cell Carcinoma Patients
OncoImmunology
Oncology
Allergy
Immunology
Subtotal Distal Pancreatectomy for Metachronous Metastatic Renal Clear Cell Carcinoma
Revista Espanola de Enfermedades Digestivas
Medicine
Gastroenterology
A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma
European Urology
Urology
Clear Cell Papillary Renal Cell Carcinoma
Archives of Pathology and Laboratory Medicine
Medicine
Forensic Medicine
Pathology
Medical Laboratory Technology
Safety and Efficacy of Sunitinib for Advanced Non-Clear Cell Renal Cell Carcinoma
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
